Business & Finance
Anpario Posts Strong H1 Growth Driven by Premium Feed Brands and U.S. Expansion
By TipRanks UK Auto-Generated Newsdesk
Anpario plc (GB:ANP) has reported robust first-half results for the six months ended 30 June 2026, with revenue increasing 7% to £24.3 million and adjusted EBITDA climbing 22% to £5.0 million. The company credited disciplined pricing and reduced underlying administrative costs for the improved profitability.
The firm's key brands, which account for nearly 80% of group revenue, saw 17% growth, contributing to record sales figures. This performance helped lift profit before tax by 11% and led to an increased interim dividend for shareholders.
Regional performance varied significantly across Anpario's markets. The IMEA region and the Americas showed the strongest growth, with the Americas now standing as the company's largest market. The integration of the Bio-Vet acquisition alongside a combined commercial team has been driving sales gains in the United States and opening new cross-selling opportunities.
In contrast, Asia experienced a 9% revenue decline, attributed primarily to reduced demand for mycotoxin binders amid economic pressures in the region and disruption linked to the Iran conflict.
Despite these regional challenges, company management expressed confidence in sustaining growth, pointing to Anpario's geographic diversification, a shift in product mix toward premium additives, and plans to rebrand the Bio-Vet range under the Anpario name.
Anpario plc is a UK-listed manufacturer specializing in natural, sustainable animal feed additives for animal health, nutrition and biosecurity. Its portfolio includes premium brands such as Orego-Stim, Optomega, pHorce, Mastercube and the Bio-Vet range, with operations spanning the Americas, India, the Middle East, Africa and Asia through direct sales and distribution partnerships.
The company's strategy centers on higher value-add products and on-farm solutions, supported by geographic diversification and a unified global commercial structure. The Bio-Vet acquisition has strengthened Anpario's position in ruminant nutrition, particularly within the U.S. market, aligning with its broader goal of moving closer to end markets and capitalizing on demand for feed additives that enhance animal performance and welfare.
Anpario's average trading volume stands at 34,556 shares, with a current market capitalization of £86.91 million.